 long-term preserv renal function patient lupu nephriti treatment cyclophosphamid prednison purpos studi long-term preserv renal function patient system lupu erythematosu activ glomerulonephr random treatment trial differ drug treatment program use low-dos oral prednison addit studi drug regimen high-dos oral prednison patient intraven cyclophosphamid oral cyclophosphamid oral azathioprin cyclophosphamid preserv renal function patient prednison result azathioprin group prednisone-onli group cyclophosphamid long-term benefit delay prevent end-stag renal diseas patient lupu nephriti